Neospark Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 14-12-2024
- Paid Up Capital ₹ 5.01 M
as on 14-12-2024
- Company Age 30 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 95.50 Cr
as on 14-12-2024
- Satisfied Charges ₹ 2.75 M
as on 14-12-2024
- Revenue -0.29%
(FY 2023)
- Profit 181561.90%
(FY 2023)
- Ebitda 21.78%
(FY 2023)
- Net Worth 2.05%
(FY 2023)
- Total Assets 0.14%
(FY 2023)
About Neospark Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.01 M.
The company currently has active open charges totaling ₹95.50 Cr. The company has closed loans amounting to ₹2.75 M, as per Ministry of Corporate Affairs (MCA) records.
Kumara Muppala, Siva Vemulapalli, Ankamma Uyyuru, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230TG1994PTC018667
- Company No.
018667
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 1994
- Date of AGM
18 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Neospark Pharma Private Limited offer?
Neospark Pharma Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Veterinary Medicines, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Neospark Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Gannamaneni  | Managing Director | 01-Nov-1994 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kumara Muppala | Director | 01-Nov-1994 | Current |
| Siva Vemulapalli | Director | 01-Nov-1994 | Current |
| Ankamma Uyyuru | Director | 01-Nov-1994 | Current |
Madhavee Vemulapalli  | Director | 06-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Neospark Pharma.
Neospark Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.29% decrease. The company also saw a substantial improvement in profitability, with a 181561.9% increase in profit. The company's net worth moved up by a moderate rise of 2.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neospark Pharma?
Unlock access to Neospark Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Neospark Drugs And Chemicals Private Limited.Active 35 years 5 monthsKumara Muppala, Siva Vemulapalli and 3 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 23 May 2011 | ₹95.50 Cr | Open |
State Bank Of India Creation Date: 20 Mar 2002 | ₹0.30 M | Satisfied |
State Bank Of India Creation Date: 10 Dec 1998 | ₹2.45 M | Satisfied |
How Many Employees Work at Neospark Pharma?
Neospark Pharma has a workforce of 1 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neospark Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neospark Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
